Log in to save to my catalogue

Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case r...

Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case r...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eaec3945848f407f83928be22d5e270f

Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report

About this item

Full title

Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report

Publisher

England: BioMed Central Ltd

Journal title

Journal of medical case reports, 2022-12, Vol.16 (1), p.456-456, Article 456

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Immune checkpoint inhibition with anti-PD(L)1 and anti-CTLA4 antibodies has significantly changed cancer treatment during the last 10 years. Nevertheless, boosting the immune system with immune checkpoint inhibition can result in immune-related adverse events, affecting different organ systems, among which the endocrine system is the most affected....

Alternative Titles

Full title

Isolated adrenocorticotropic hormone deficiency and sialadenitis associated with nivolumab: a case report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eaec3945848f407f83928be22d5e270f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eaec3945848f407f83928be22d5e270f

Other Identifiers

ISSN

1752-1947

E-ISSN

1752-1947

DOI

10.1186/s13256-022-03663-6

How to access this item